DRIED BLOOD MICROSAMPLING DEVICE MARKET

INTRODUCTION 

For the purpose of collecting blood remotely, a dried blood sample device was created using volumetric absorptive microsampling.Dried blood sample is drawing a tiny amount of blood from a research subject via a pinprick or another method, transferring it to a card made of cellulose or polymer paper, drying it, and then sending it to the lab for examination.

A few drops of blood extracted using a lancet from the finger, heel, or toe are applied to specially designed absorbent filter paper to create dried blood spot specimens. Most laboratory techniques need the blood to be fully soaked into the paper before being air dried for a number of hours to test for antibodies, antigens, or nucleic acids.

Dried blood samples often last at room temperature for a few weeks before losing their viability. Overall, dried blood is far more stable at ambient temperatures than wet blood.

DRIED BLOOD MICROSAMPLING DEVICE MARKET SIZE AND FORECAST

The Global Dried Blood MicroSampling Device market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.

DRIED BLOOD MICROSAMPLING DEVICE MARKETNEW PRODUCT LAUNCH

Trajan’s Microsampling Devices Earn CE-IVD Registration.Trajan Scientific and Medical, a leading provider of analytical and life sciences products and solutions,  the regulatory approval of its Neoteryx remote blood microsampling devices, the Mitra and hemaPEN for clinical use .

Trajan has successfully met the product safety and performance standards set out by the European Union's In Vitro Diagnostic Medical Devices Regulation (IVDR) and the Medicines and Healthcare Products Regulatory Agency (MHRA).

The Mitra device is a finger-stick blood collection method for transportation of dried samples to the lab. It is based on volumetric absorptive microsampling using VAMS technology.

Using a single finger-stick, the hemaPEN gadget, based on volumetric microsampling using capillary and next-generation DBS technology, simultaneously collects 4 equal-volume DBS blood samples.

Blood samples may be remotely collected using the hemaPEN and Mitra devices in a simple, very painless procedure. In comparison to conventional DBS or other remote blood sampling methods, these devices give accurate quantities and great sample quality. They may be used to transport dried blood samples by ordinary mail.

DRIED BLOOD MICROSAMPLING DEVICE MARKETCOMPANY PROFILE

• QIAGEN
• Roche
• Shimadzu Corporation
• Ahlstrom-Munksjö
• Pall Corporation

DRIED BLOOD MICROSAMPLING DEVICE MARKETTHIS REPORT WILL ANSWER FOLLOWING QUESTIONS

1. How many Blood MicroSampling Devices are manufactured per annum globally? Who are the sub-component suppliers in different regions?
2. Cost breakup of a Global Blood MicroSampling Device and key vendor selection criteria
3. Where is the Blood MicroSampling Device manufactured? What is the average margin per unit?
4. Market share of Global Blood MicroSampling Device market manufacturers and their upcoming products
5. Cost advantage for OEMs who manufacture Global Blood MicroSampling Device in-house
6. key predictions for next 5 years in Global Blood MicroSampling Device market
7. Average B-2-B Blood MicroSampling Device market price in all segments
8. Latest trends in Blood MicroSampling Device market, by every market segment
9. The market size (both volume and value) of the Blood MicroSampling Device market in 2024-2030 and every year in between?
10. Production breakup of Blood MicroSampling Device market, by suppliers and their OEM relationship